U.S. market Closed. Opens in 15 hours 14 minutes

CELUW | Celularity Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue22.77M17.98M21.34M14.28M21.15M
Cost of Revenue16.02M19.66M9.65M4.93M6.32M
Gross Profit6.75M-1.69M11.68M9.35M14.82M
Operating Expenses83.23M146.58M159.69M87.44M1.68M
Selling, General & Admin50.58M66.02M71.34M31.34M1.68M
Research & Development30.46M78.36M88.35M52.71M46.05M
Other Operating Expenses-7.47M2.19M50.75M3.39MN/A
Operating Income-192.29M-25.60M-148.01M-78.09M-1.68M
Other Expenses / Income-117.11M39.80M47.91M-134.84M8.23M
Before Tax Income-196.28M14.21M-100.10M-212.93M6.55M
Income Tax Expenses10.00K13.00K20.00K-4.70M668.23K
Net Income-196.29M14.19M-100.12M-208.23M5.88M
Interest Expenses3.02M-164.78M3.17M2.35M-3.75M
Basic Shares Outstanding17.81M15.77M6.71M1.84M2.39M
Diluted Shares Outstanding17.81M14.98M6.71M1.84M2.39M
EBITDA-74.30M-141.13M-96.93M-65.45M-1.68M
EBITDA Margin-326.30%-785.17%-454.31%-458.40%-7.96%
EBIT-193.27M-150.57M-96.93M-210.58M2.80M
EBIT Margin-848.75%-837.67%-454.31%-1,474.85%13.25%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙